Sbir phase I award

Ended Definitive Contract Awarded Last action

Contract number
HHSN261201100053C
Awardee
Awarding agency
Obligated
$200,000

Award facts

Contract value 100% obligated
$200,000.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
334510 Electromedical and Electrotherapeutic Apparatus Manufacturing
PSC
AJ91 R&D- General Science/Technology: Other (Basic Research)
Set-aside
Total Small Business
Competition
Full and Open Competition after exclusion of sources · 251 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Sunnyvale, CA 94085, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Change Order 2 $0
Funding Only Action 1 · The purpose of this contract is to develop a prototype etds at an engineered drug-DYE release rate, and demonstrate POC theranostic activity in a mouse… $180,000
Original award $20,000

Quick answers

Who was awarded contract HHSN261201100053C?

HHSN261201100053C was awarded to Aravasc, Inc. by National Cancer Institute (National Institutes of Health) on September 27, 2011.

How much is contract HHSN261201100053C worth?

The government has obligated $200,000 on HHSN261201100053C.

Was contract HHSN261201100053C competed?

The extent of competition for HHSN261201100053C was full and open competition after exclusion of sources. The government received 251 offers. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award